Efficacy and safety of CSL112 (apolipoprotein A-I) on modulation of HDL-Related biomarkers and reverse cholesterol transport in atherosclerosis and myocardial infarction: a systematic review and meta-analysis
{{output}}
Background: Despite statin therapy, cardiovascular disease remains a leading cause of mortality. CSL112 enhances HDL function and reverse cholesterol transport, offering a novel strategy for atherosclerotic cardiovascular disease... ...
